Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense With Biothrax® (Anthrax Vaccine Adsorbed)
Emergent BioSolutions宣佈行使2000萬美元的選擇權,向美國國防部供應Biothrax®(吸附性炭疽生物-疫苗)
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense With Biothrax® (Anthrax Vaccine Adsorbed)
Emergent BioSolutions宣佈行使2000萬美元的選擇權,向美國國防部供應Biothrax®(吸附性炭疽生物-疫苗)
譯文內容由第三人軟體翻譯。
使用瀏覽器的分享功能,分享給你的好友吧